NEW YORK (GenomeWeb News) – Biomolecular analysis and proteomics company Phoenix S&T has received a $500,000 investment from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania.
BioAdvance said today that it has provided the Chester, Pa.-based company with the funding as one of three firms it has newly invested in with a total of $1.5 million.
PST has patented injection molded nanospray devices used in biomolecular analysis for proteomics and clinical diagnostics applications.
BioAdvance derives funding from the $20 million Greenhouse Fund that was established in 2002. It provides initial seed funds of up to $500,000, and it provides business assistance and other resources.